Saltex Pharma evidences a One Step Rapid Antibody test (BIOZEK) that detects COVID-19 antibodies at a much earlier stage post onset of symptoms - Seite 2

A further benefit of the BIOZEK Test, as confirmed by a joint study conducted by Public Health England and the University of Oxford, is its ability to actively detect antibodies at an acceptable level from day 10 onwards post symptom onset. When compared to existing antibody tests already approved by Health Canada, this significantly improves on the existing capabilities, where the current approved tests show acceptable detection rates at greater than 20 days post symptom onset.

Figure 1: Definitive results from selected study centers that compared the BIOZEK Rapid Antibody test performance vs traditional PCR testing methodologies

Institution	n (Patients/Sample)	Sensitivity	Specificity
Pasteur Institute, Paris, France	80	98%	98-100%
University Medical Center Amsterdam, Netherlands Streeklab Haarlem, Netherlands	368	100%	98.10%
Pro Health Medical Nederwart, Netherlands	212	98.80%	99.20%
National Institute for Public Health and the Environment, Ministry of Health, Netherlands.	489	95.30%	98.20%

 

About Saltex Pharma

Saltex Pharma is a leading supplier of goods and services to government entities and healthcare providers around the world.

Saltex Pharma's mission is to expand the reach of niche pharmaceutical and medical device products to new markets, ensuring equal access to new and innovative technologies that support better health and care for patients.

Since their inception in 2009, Saltex Pharma has facilitated access to new markets for several pharmaceutical and biotechnology companies, and supported local governments and healthcare providers with the procurement of licensed medical goods and devices.

For more information about Saltex Pharma please visit www.saltexpharma.com

About BIOZEK One Step Rapid Antibody Test

• CE Certified
• ISO 13485 Certified
• Manufactured in Europe
• Highly Selective and Specific
• Actively used across healthcare settings in Europe and the Far East
• Pending Health Canada Authorization